Of 21 DNA methylation-associated genes detected, mutations in TET1 were observed to be significantly associated with better responses to ICIs in patients with NSCLC, bladder cancer, HNSCC, melanoma, and esophagogastric cancer [17], but its potential role in colon cancer was not analyzed. The gene discussed is TET1; the disease is malignant colon neoplasm.